Providence Willamette Falls Medical Center is a not-for-profit acute care hospital operated by Providence Health & Services in Oregon City, Oregon, United States. Established in 1954 as Doctors' Hospital, the hospital moved to its current location in 1961 and has 143 licensed beds at its 243,000-square-foot facility.

There are 143 beds in Providence Willamette Falls Medical Center.

During the past decade, Providence Willamette Falls Medical Center conducted 46 clinical trials. In the 10-year time frame, 46 clinical trials started and 87 clinical trials were completed, i.e. on average, 189.1% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 53 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Providence Willamette Falls Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 52 trials, followed by "SWOG Cancer Research Network" with 34 trials sponsored, "Alliance for Clinical Trials in Oncology" with 28 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 4 trials sponsored and "GOG Foundation" with 4 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Providence Willamette Falls Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 77 trials as a collaborator, "NRG Oncology" with 8 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "SWOG Cancer Research Network" with 3 trials as a collaborator and "Astellas Pharma US, Inc." with 2 trials as a collaborator. Other collaborators include 28 different institutions and companies that were collaborators in the rest 32 trials.

According to Clinical.Site data, the most researched conditions in "Providence Willamette Falls Medical Center" are "Breast Cancer" (15 trials), "Lymphoma" (9 trials), "Recurrent Breast Carcinoma" (8 trials), "Recurrent Squamous Cell Lung Carcinoma" (8 trials) and "Stage IV Breast Cancer AJCC v6 and v7" (6 trials). Many other conditions were trialed in "Providence Willamette Falls Medical Center" in a lesser frequency.

Most popular intervention types in "Providence Willamette Falls Medical Center" are "Drug" (107 trials), "Other" (85 trials), "Biological" (40 trials), "Procedure" (21 trials) and "Radiation" (9 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (49 trials), "Quality-of-Life Assessment" (23 trials), "Paclitaxel" (12 trials), "placebo" (11 trials) and "Questionnaire Administration" (10 trials). Other intervention names were less common.

The vast majority of trials in "Providence Willamette Falls Medical Center" are 101 trials for "All" genders, 28 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Providence Willamette Falls Medical Center". undefined are not yet recruiting, 5 are recruiting, 66 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 50 completed trials in Providence Willamette Falls Medical Center, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Providence Willamette Falls Medical Center, 6 "Phase 1" clinical trials were conducted, 54 "Phase 2" clinical trials and 68 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".